Barrick Mining Corporation

Forgent Power Solutions, Inc.

Eikon Therapeutics, Inc. Common Stock

Veradermics Inc.

Elon Musk is pushing for accelerated inclusion of his space company SpaceX in major stock indexes after its IPO, and Nasdaq doesn't mind. Swiss agrochemical giant Syngenta resumed preparations to list for up to $10 billion. Norwegian software developer for accountants Visma and mobile advertising platform Liftoff Mobile changed their minds about going public in the midst of the "software apocalypse". The main events on the IPO market during the week are in our selection.

SpaceX, Syngenta and the "software apocalypse": the main thing about IPOs by February 8

Sleep-deprived people <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11611806/">stop perceiving</a> negative feedback, i.e. a losing trade no longer makes the tired person's brain adjust the investment strategy. At the same time, the brain switches to the energy-saving mode and starts using simplified thinking patterns. And although in the world of finance it is commonly believed that success depends on intelligence, in reality this is far from true. Let's see how fatigue not only makes us risky, but also inconsistent in our investments.

The cost of burnout: how sleep deprivation and everyday stress reduce investment returns

Diageo plc

Pernod Ricard SA

Davide Campari-Milano N.V.

Brown-Forman Corporation

Remy Cointreau SA

The five largest publicly traded producers - Diageo, Pernod Ricard, Campari, Brown-Forman and Rémy Cointreau - have combined stocks of aged spirits at $22 billion, the highest level in 10 years, the Financial Times <a href="https://www.ft.com/content/9e6f024c-63b5-493f-bb35-6c1c05e90e55">wrote </a>.

People are drinking less. How alcohol producers are dealing with this 

NextEra Energy, Inc.

Talen Energy Corporation

Vistra Corp.

Constellation Energy Corporation

PWR Holdings Limited

GE Vernova Inc.

National Atomic Company Kazatomprom JSC

Cameco Corporation

In the U.S., power <a href="https://www.spglobal.com/energy/en/news-research/latest-news/electric-power/012926-data-center-opposition-gains-momentum-as-power-demand-spikes">consumption by </a>data centers will grow to 82.3 gigawatts this year, which is needed to power IT equipment, cooling systems, lighting, etc. This is a 28% increase over 2025 and double the level <a href="https://www.spglobal.com/energy/en/news-research/latest-news/electric-power/012926-data-center-opposition-gains-momentum-as-power-demand-spikes">of </a>three years ago. That's a 28% increase from 2025 and more than double the level of three years ago. This is the latest data from S&amp;P Global Market Intelligence 451 Research.

Rally of nuclear power companies: which stocks to choose for investors

The Estee Lauder Companies Inc.

The collapse of Estée Lauder's quotations after a weak forecast for fiscal year 2026 is seen by Citi analysts as a good entry point. The bank recommended buying the cosmetics company's shares on the downturn, pointing to signs of recovery in key markets.

Estée Lauder stock collapse presents a buying opportunity on the downturn - Citi

NVIDIA Corporation

Advanced Micro Devices, Inc.

Broadcom Inc.

Quotes for chipmaker Nvidia jumped nearly 8% on Friday, February 6. That's the strongest increase in nine months, according to Dow Jones Market Data <a href="https://www.marketwatch.com/story/nvidias-stock-shoots-toward-best-day-since-april-as-tech-sector-rebounds-7211f5bd">cited</a> by MarketWatch. Investors have started actively buying up securities of companies that could benefit from the colossal spending that tech giants have promised to devote this year to infrastructure for artificial intelligence. Friday's rally ended Nvidia's longest losing streak since Sept. 3, when the stock fell in price for five consecutive trading sessions due to a general market sell-off.

Nvidia has its best growth since April. It could be the beneficiary of Big Tech's giant spending spree

Caterpillar Inc.

Palantir Technologies Inc.

Oracle Corporation

The bull market is not dead, but aging, according to investment firm Bellwether Wealth

The Dow Jones broke the 50,000-point mark for the first time. The market rebounded after the sell-off

Micron Technology, Inc.

The bank estimates that the memory chip shortage that has sent the company's quotes skyrocketing will persist until the end of 2027

UBS raised its target on Micron shares after a long rally. Why are they still worth buying?

Data

Bank of America Corporation

The Magnificent Seven's market leadership faces a "major threat"

BofA calls smid-cap stocks 'best play' ahead of U.S. midterms

Pandora A/S

Shares of Danish jewellery giant Pandora rose 5.6% in trading in Copenhagen on Thursday and continued higher after early trading on Friday. Despite weak guidance for 2026 and the suspension of share buybacks, the stock was supported by falling silver prices, Bloomberg <a href="https://www.bloomberg.com/news/articles/2026-02-05/pandora-sees-sales-slowing-pauses-buyback-as-silver-prices-bite?embedded-checkout=true#:~:text=Shares%20rose%20as%20much%20as%207.5%25%20in%20Copenhagen%20as%20silver%20prices%20tumbling%20outweighed%20concerns%20around%20guidance.">reported</a>. A day earlier, Pandora announced plans to partially shift away from the precious metal in favor of platinum-plated jewelry. On Friday, several analysts revised their target price on the company’s shares.

Pandora cuts sales guidance and pauses buybacks, but the stock is still rising

Pfizer Inc.

Sanofi

AgomAb Therapeutics N.V. American Depositary Shares

Agomab's Crohn's disease therapy is already being clinically tested

Agomab Therapeutics IPO: Pfizer and Sanofi-backed biotech starts trading

Once Upon A Farm Pbc

The company is listed on the NYSE under the ticker OFRM

Once Upon a Farm IPO: Shares of Jennifer Garner-cofounded company start trading 

Janux Therapeutics, Inc.

Legend Biotech Corporation

4D Molecular Therapeutics, Inc.

Arcturus Therapeutics Holdings Inc.

Altimmune, Inc.

Black Diamond Therapeutics, Inc.

The global biotechnology market was valued at about $1.65 trillion in 2025 and is projected to grow to $5.22 trillion by 2034 at a compound annual growth rate of 13.67%, according to <a href="https://straitsresearch.com/report/biotechnology-market">Straits Research</a>. The U.S. market remains the largest globally: it was worth $552.39 billion in 2023 and is expected to reach $1.24 trillion by 2030. Insider Monkey has <a href="https://www.insidermonkey.com/blog/20-best-biotech-stocks-under-20-to-buy-now-1685703/">selected</a>&nbsp;20 biotech companies trading below $20 per share that are widely held by hedge funds.

Insider Monkey names 20 under-$20 biotech stocks popular with hedge funds

Small Caps

Important news and analysis of global stock markets, plus crypto, bonds, and ETFs

Investment and Finance News